Moe, Robert; Bagdon, Robert E.; Zbinden, Gerhard
January 1962
Angiology;Jan1962, Vol. 13 Issue 1, p4
Academic Journal
Discusses the effects of tranquilizers on myocardial metabolism. Elevation of free fatty acids which could be reduced by the central nervous and peripheral autonomic effects of the tranquilizers; Significance of tranquilizer-induced alteration of the physiologic function of the central nervous and peripheral autonomic systems; Changes in many of the myocardial responses to stress situations.


Related Articles

  • Cerebral metabolic changes induced by clozapine in schizophrenia and related to clinical improvement. Molina, Vicente; Gispert, Juan D.; Reig, Santiago; Sanz, Javier; Pascau, Javier; Santos, Andrés; Desco, Manuel; Palomo, Tomàs // Psychopharmacology;Feb2005, Vol. 178 Issue 1, p17 

    Rationale: The study of the different effects on brain metabolism between typical and atypical antipsychotics would aid in understanding their mechanisms of action. Clozapine is of special interest, since it is one of the most effective antipsychotic drugs and demonstrates a distinctive...

  • Pharmacokinetics of reboxetine in healthy volunteers with different ethnic descents. Hendershot, Pamela E.; Fleishaker, Joseph C.; Lin, Keh-Ming; Nuccio, Inocencia D.; Poland, Russell E. // Psychopharmacology;2001, Vol. 155 Issue 2, p148 

    Abstract Rationale: Ethnicity can affect the pharmacokinetics and pharmacodynamics of psychopharmacologic drugs. Objectives: Reboxetine disposition differences among Asians, blacks, and Caucasians were examined. Methods: Healthy subjects (12 Asians, 12 blacks, 12 Caucasians) received a single...

  • The wise use of psychiatric drugs. Akiskal, Hagop S.; Jensvold, Margaret F. // Patient Care;11/15/1994, Vol. 28 Issue 18, p82 

    Discusses the prudent use of psychiatric drugs as powerful tools in an integrated approach to mental illness. Factors to consider in choosing antidepressants; Use of anxiolytics and sedatives; Use of antipsychotics; Serotoninergic agents; Atypical antidepressants. INSETS: Gender and...

  • Psychotropic drugs and accidents in a general practice. Binnie, G.A. // British Medical Journal (Clinical Research Edition);11/5/1983, Vol. 287 Issue 6402, p1349 

    Focuses on psychotropic drugs and accidents in medical practice. Risk in taking psychotic drugs in medical practice; Effect of the drugs on patients not taking tranquilizers; Association of traffic accidents with the intake of the drugs.

  • The four-plates test-retest paradigm to discriminate anxiolytic effects. Ripoll, Nadège; Dhonnchadha, Bríd Áine Nic; S&ecute;bille, Véronique; Bourin, Michel; Hascoët, Martine // Psychopharmacology;Jun2005, Vol. 180 Issue 1, p73 

    Presents a study which examined the capacity of the four-plates test (FPT) to discriminate benzodiazepines (BZD) from other non-BZD anxiolytics in experienced mice. Limitations of BZD; Effect of alprazolam on mouse behavior in the FPT; Results of the study.

  • Characterisation of the Pharmacokinetics of the Fentanyl HCl Patient-Controlled Transdermal System (PCTS). Sathyan, Gayatri; Jaskowiak, Jennifer; Evashenk, Mark; Gupta, Suneel // Clinical Pharmacokinetics;2005 Supplement 1, Vol. 44, p7 

    Introduction: The fentanyl HCI patient-controlled transdermal system (PCTS) is a self-contained, preprogrammed, noninvasive analgesic delivery system for acute pain management. We carried out three studies with the following objectives: study I to evaluate the relationship between fentanyl...

  • Pharmacokinetics of Deramciclane, a Novel Anxiolytic Agent, after Intravenous and Oral Administration. Huupponen, Risto; Paija, Outi; Salonen, Markku; Björklund, Harry; Rouru, Juha; Anttila, Markku // Drugs in R&D;2003, Vol. 4 Issue 6, p339 

    Background and objective: Deramciclane is a new compound that has shown anxiolytic effects in animal experiments and in human studies. The aim of this study was to determine the pharmacokinetic parameters of deramciclane after intravenous and oral administration, and its oral bioavailability....

  • paroxetine hydrochloride.  // Davis's Drug Guide for Nurses, 10th edition;2007, p920 

    This article presents information on the drug paroxetine hydrochloride, which is marketed as Paxil. It is classified as antianxiety agents or antidepressants and pharmacologically it falls under selective serotonin reuptake inhibitors. It is used to treat depression, panic disorder, social...

  • Medicating Grief With Potentially Addictive Drugs.  // HealthFacts;Nov2007, Vol. 32 Issue 11, p3 

    The article discusses research being done on the prescription of benzodiazepine drugs for use by elderly people. It references a study by Joan M. Cook and colleagues published in the "Archives of Internal Medicine." It cites the findings of the study, which found that some physicians in the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics